Piramal to expand in API manufacturing capabilities with $55m
Piramal Pharma Solutions (PPS) is set to invest $55m across its production sites in North America and Asia in order to expand its active pharmaceutical ingredients (API) manufacturing capabilities and capacities. (Source: Pharmaceutical Technology)
Source: Pharmaceutical Technology - October 9, 2017 Category: Pharmaceuticals Source Type: news
EMA accepts marketing application for Imfinzi to treat NSCLC patients
The European Medicines Agency (EMA) has accepted a marketing authorisation application (MAA) for AstraZeneca and MedImmune ’s Imfinzi (durvalumab) to treat patients with locally advanced, unresectable non-small-cell lung cancer (NSCLC). (Source: Pharmaceutical Technology)
Source: Pharmaceutical Technology - October 9, 2017 Category: Pharmaceuticals Source Type: news
US FDA approves Flexion ’s Zilretta to treat osteoarthritis knee pain
The US Food and Drug Administration (FDA) has granted approval for specialist pharmaceutical firm Flexion Therapeutics ’s Zilretta for the treatment of osteoarthritis (OA) knee pain. (Source: Pharmaceutical Technology)
Source: Pharmaceutical Technology - October 9, 2017 Category: Pharmaceuticals Source Type: news
Autoinjectors: From Planning to Launch
Looking at the rising trend towards self-administration therapies, injectable drug delivery devices such as pen injectors, autoinjectors and needle-free injectors show a significant growth potential in the near future. (Source: Pharmaceutical Technology)
Source: Pharmaceutical Technology - October 9, 2017 Category: Pharmaceuticals Source Type: news
Medelpharm to Attend CPhI Frankfurt
Medelpharm has announced it will be showcasing the renowned STYL'One Evolution tableting instrument with its latest innovative accessories at CPhI Frankfurt. (Source: Pharmaceutical Technology)
Source: Pharmaceutical Technology - October 9, 2017 Category: Pharmaceuticals Source Type: news
Do You Have a Robust and Compliant CAPA System?
Are you struggling from death by corrective and preventative action (CAPA)? Do you have a robust and compliant CAPA system? (Source: Pharmaceutical Technology)
Source: Pharmaceutical Technology - October 9, 2017 Category: Pharmaceuticals Source Type: news
European Commission grants orphan drug status to Apogenix ’s asunercept for MDS
German biopharmaceutical company Apogenix ’s asunercept (APG101) has received orphan drug designation from the European Commission (EC) to treat patients with myelodysplastic syndromes (MDS). (Source: Pharmaceutical Technology)
Source: Pharmaceutical Technology - October 8, 2017 Category: Pharmaceuticals Source Type: news
Avara Pharmaceutical buys AstraZeneca ’s Reims solid dosage facility
Avara Pharmaceutical Services has closed an agreement to purchase AstraZeneca ’s secondary solid dosage, form-manufacturing, packaging and distribution facility located in Reims, France. (Source: Pharmaceutical Technology)
Source: Pharmaceutical Technology - October 8, 2017 Category: Pharmaceuticals Source Type: news
Researchers to use supercomputing technology for cancer drugs discovery
Researchers from the University of California (UC) have collaborated with affiliated national laboratory scientists and industry experts to use advanced supercomputing capabilities for the development of new and personalised cancer treatments. (Source: Pharmaceutical Technology)
Source: Pharmaceutical Technology - October 8, 2017 Category: Pharmaceuticals Source Type: news
Silicified Microcrystalline Cellulose
Excipients play a major role in the development of tablets and capsules for the health science industry. As active pharmaceutical ingredients (API), and manufacturing processes evolve, the need for excipients with greater flexibility increases. (Source: Pharmaceutical Technology)
Source: Pharmaceutical Technology - October 8, 2017 Category: Pharmaceuticals Source Type: news
JRS to Attend CPhI Worldwide Trade Show
JRS has announced it will be attending CPhI Worldwide. (Source: Pharmaceutical Technology)
Source: Pharmaceutical Technology - October 8, 2017 Category: Pharmaceuticals Source Type: news
EMBO CAPS ® by Suheung -Empty Hard Capsules for Pharmaceutical Applications
EMBO CAPS ® is a range of highly customisable and secure encapsulation technologies that allow drug developers to achieve wide product diversification. (Source: Pharmaceutical Technology)
Source: Pharmaceutical Technology - October 5, 2017 Category: Pharmaceuticals Source Type: news
Synthon ’s generic version of Copaxone at 40mg receives European approval to treat MS
Netherlands-based pharmaceutical company Synthon ’s 40mg/ml of glatiramer acetate has received regulatory approval for the treatment of relapsing forms of multiple sclerosis (MS) in Europe. (Source: Pharmaceutical Technology)
Source: Pharmaceutical Technology - October 5, 2017 Category: Pharmaceuticals Source Type: news
Netherlands Cancer Institute scientists discover new way to combat cancer
A research team from the Netherlands Cancer Institute has discovered the underlying mechanism of cancer drug addiction that can lead to the development of more rational alternating therapies to kill cancer cells. (Source: Pharmaceutical Technology)
Source: Pharmaceutical Technology - October 5, 2017 Category: Pharmaceuticals Source Type: news
M & As this week: Stallergenes Greer, Medicure, Eris Lifesciences
UK-based biopharmaceutical company Stallergenes Greer has acquired Canadian allergy immunotherapy provider Medic Savoure. (Source: Pharmaceutical Technology)
Source: Pharmaceutical Technology - October 5, 2017 Category: Pharmaceuticals Source Type: news
